Form 8-K - Current report:
SEC Accession No. 0001299933-11-003050
Filing Date
2011-10-18
Accepted
2011-10-17 17:43:29
Documents
4
Period of Report
2011-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_43227.htm 8-K 12102
2 EX-10.27 exhibit1.htm EX-10.27 20048
3 EX-99.1 exhibit2.htm EX-99.1 6423
4 GRAPHIC e34723-112861055271237110_1.jpg GRAPHIC 26836
  Complete submission text file 0001299933-11-003050.txt   76978
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 111144475
SIC: 2834 Pharmaceutical Preparations